Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'

doi:10.1097/HJH.0000000000002481

Comment

. 2020 Jun;38(6):1189-1198.

doi: 10.1097/HJH.0000000000002481.

Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'

Erkan Cüre^{1

2}, Medine Cumhur Cüre²

Affiliations

¹ Department of Internal Medicine, Ota & Jinemed Hospital, Istanbul.
² Department of Biochemistry, Private Practice, Istanbul, Turkey.

PMID: 32371810
PMCID: PMC7236845
DOI: 10.1097/HJH.0000000000002481

Comment

Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'

Erkan Cüre et al. J Hypertens. 2020 Jun.

. 2020 Jun;38(6):1189-1198.

doi: 10.1097/HJH.0000000000002481.

Authors

Erkan Cüre^{1

2}, Medine Cumhur Cüre²

Affiliations

¹ Department of Internal Medicine, Ota & Jinemed Hospital, Istanbul.
² Department of Biochemistry, Private Practice, Istanbul, Turkey.

PMID: 32371810
PMCID: PMC7236845
DOI: 10.1097/HJH.0000000000002481

No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Comment on

Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
Esler M, Esler D. Esler M, et al. J Hypertens. 2020 May;38(5):781-782. doi: 10.1097/HJH.0000000000002450. J Hypertens. 2020. PMID: 32195824 No abstract available.

Cited by

Angiotensin II, III, and IV may be important in the progression of COVID-19.
Cure E, Ilcol TB, Cumhur Cure M. Cure E, et al. J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972019. doi: 10.1177/1470320320972019. J Renin Angiotensin Aldosterone Syst. 2020. PMID: 33169633 Free PMC article. No abstract available.
Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.
Gęca T, Wojtowicz K, Guzik P, Góra T. Gęca T, et al. Int J Environ Res Public Health. 2022 May 27;19(11):6555. doi: 10.3390/ijerph19116555. Int J Environ Res Public Health. 2022. PMID: 35682137 Free PMC article. Review.
Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review.
Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Viswanathan V, et al. World J Diabetes. 2021 Mar 15;12(3):215-237. doi: 10.4239/wjd.v12.i3.215. World J Diabetes. 2021. PMID: 33758644 Free PMC article. Review.
Reply: Possible impact of membrane ACE2 expression on COVID-19 infection.
Esler M, Esler D. Esler M, et al. J Hypertens. 2020 Jun;38(6):1192-1194. doi: 10.1097/HJH.0000000000002484. J Hypertens. 2020. PMID: 32371814 Free PMC article. No abstract available.
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H. Sackin H. Med Hypotheses. 2021 Jul;152:110609. doi: 10.1016/j.mehy.2021.110609. Epub 2021 May 12. Med Hypotheses. 2021. PMID: 34048987 Free PMC article.

See all "Cited by" articles

References

1. Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID- 19 pandemic? J Hypertens 2020; 38:781–782. - PubMed
1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8:e21. - PMC - PubMed
1. Brosnihan KB, Neves LA, Chappell MC. Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension? Hypertension 2005; 46:1097–1099. - PubMed
1. de Albuquerque Rocha N, Neeland IJ, McCullough PA, Toto RD, McGuire DK. Effects of sodium glucose co-transporter 2 inhibitors on the kidney. Diab Vasc Dis Res 2018; 15:375–386. - PubMed
1. Romani-Perez M, Outeirino-Iglesias V, Moya CM, Santisteban P, Gonzalez-Matias LC, Vigo E, et al. Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology 2015; 156:3559–3569. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID- 19 pandemic? J Hypertens 2020; 38:781–782. - PubMed

[2] Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID- 19 pandemic? J Hypertens 2020; 38:781–782. - PubMed

[3] Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8:e21. - PMC - PubMed

[4] Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8:e21. - PMC - PubMed

[5] Brosnihan KB, Neves LA, Chappell MC. Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension? Hypertension 2005; 46:1097–1099. - PubMed

[6] Brosnihan KB, Neves LA, Chappell MC. Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension? Hypertension 2005; 46:1097–1099. - PubMed

[7] de Albuquerque Rocha N, Neeland IJ, McCullough PA, Toto RD, McGuire DK. Effects of sodium glucose co-transporter 2 inhibitors on the kidney. Diab Vasc Dis Res 2018; 15:375–386. - PubMed

[8] de Albuquerque Rocha N, Neeland IJ, McCullough PA, Toto RD, McGuire DK. Effects of sodium glucose co-transporter 2 inhibitors on the kidney. Diab Vasc Dis Res 2018; 15:375–386. - PubMed

[9] Romani-Perez M, Outeirino-Iglesias V, Moya CM, Santisteban P, Gonzalez-Matias LC, Vigo E, et al. Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology 2015; 156:3559–3569. - PubMed

[10] Romani-Perez M, Outeirino-Iglesias V, Moya CM, Santisteban P, Gonzalez-Matias LC, Vigo E, et al. Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology 2015; 156:3559–3569. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'

Affiliations

Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources